期刊文献+

酮洛芬肠溶口腔崩解片的处方优化 被引量:4

Formulation of ketoprofen enteric and rapidly disintegrating tablets
下载PDF
导出
摘要 目的优化酮洛芬肠溶口腔崩解片的处方,考察不同压片力和不同微晶纤维素与甘露醇比例对空白崩解片孔隙率、抗张强度和崩解时限的影响。方法采用乳化溶剂扩散法制备酮洛芬肠溶微球;以微球为原料,采用粉末直接压片法制备口腔崩解片。用Statistica统计软件对处方组成进行优化,确定微晶纤维素与甘露醇的比例。结果微晶纤维素用量一定时,随压片力的增大,空白崩解片的孔隙率减小,抗张强度增大,崩解时限延长;压片力一定时,随微晶纤维素用量的增加,空白崩解片的孔隙率和抗张强度增大,崩解时限延长;根据处方优化的结果,选择微晶纤维素与甘露醇质量比为3∶1。当片剂中加入质量分数为8%的PVPP作为崩解剂时,空白崩解片的抗张强度略微增加,崩解时限显著缩短。结论根据优化后的处方,采用粉末直接压片法制备的酮洛芬肠溶口腔崩解片符合设计要求。 Objective To optimize the preparation of ketoprofen enteric and rapidly disintegrating tablets. Methods The effects of different pressures and MCC to mannitol ratios on the porosity, tensile strength ( St) and disintegration time (/d) of blank tablets were investigated. The optimal formulation was picked out by the analysis of Statistica software. The effect of different kinds of disintegrants and their amounts on St and td of blank tablets were also tested. Then, ketoprofen enteric and rapidly disintegrating tablets were prepared by direct compression method. Results The porosity of blank tablets was decreased gradually and St and td were increased significantly with the increase of the pressure. The porosity and St of blank tablets were increased, while td was decreased under the same compression when the ratios of MCC to mannitol was increased. When MCC-mannitol ratio was three and the amount of PVPP was 8 %, the blank tablets were fine at St and td. Conclusions Ketoprofen enteric and rapidly disintegrating tablets meet the requirements of the standard.
出处 《沈阳药科大学学报》 CAS CSCD 北大核心 2006年第10期625-629,共5页 Journal of Shenyang Pharmaceutical University
关键词 酮洛芬 肠溶微球 口腔崩解片 处方优化 ketoprofen enteric microspheres rapidly disintegrating tablet formulation optimization
  • 相关文献

参考文献7

  • 1何凤慈,陈亮,蒋耀光,孟德胜,向明凤.酮洛芬及其手性对映体的研究进展[J].中国药房,2004,15(4):244-246. 被引量:4
  • 2Giumchede P,Maggi L,Conte U,et al.Ketoprofen pulsatile absorption from 'multiple unit' hydrophilic matrices[J].Int J Pharm,1991,(77):177-181.
  • 3刘梅,崔光华.口腔速释片的进展及前景[J].中国药学杂志,2001,36(9):580-583. 被引量:31
  • 4张建春,蒋雪涛,邓明德,陈鼎继.口腔速释给药系统研究进展[J].解放军药学学报,2000,16(4):206-207. 被引量:17
  • 5Bi Yun-xia,Sunada H,Yonezawa Y,et al.Evaluation of rapidly disintegrating tablets prepared by a direct compression method[J].Drug Dev Ind Pharm,1999,25(5):571 -581.
  • 6Bi Yun-xia,Sunada H,Yonezawa Y,et al.Preparation and evaluation of a compressed tablet rapidly disintegrating in the oral cavity[J].Chem Pharm Bull,1996,44(11):2121-2127.
  • 7国家药典委员会.中华人民共和国药典[Z].北京:化学工业出版社,2005.附录.

二级参考文献22

  • 1张艳红,张茂森.新型口服速溶制剂──冻干速溶片[J].国外医学(药学分册),1996,23(4):202-206. 被引量:15
  • 2渡边敦.老人适用的新口腔剂型-不用水的口腔速溶片[J].药剂学(日文),1994,54(2):103-103.
  • 3罗明生 高天惠.药剂辅料大全[M].成都:四川科学技术出版社,1995.46.
  • 4Ferrero C,Munoz N,Velasco MV,et al.Disintegrating efficiency of croscarmellose sodium indirect compression formulation[J].Int J Pharml,1997,(147)11
  • 5Nakamichi k,Izuini S,Yasuura H.Manufature of fast solube tablets[P].US,Pat.WO 93 15,729,1993
  • 6Peter V,Richard Y,Zydis-A novel fast dissolving dosage form Manuf.Chem.February[M],1990.36
  • 7Yoshiteru W,Kei-ichi K,Yoshiko Z,et al.New compressed tablet disintegrating in saliva in the mouth using crystalline cellulose and disintegrant[J].Biol Phar Bull,18(9):1 308
  • 8Yunxia B,Hisakazu S,Yorinobu Y,et al.Preparation and Evaluation of a compressed tablet rapidly disintegrating in the oral cavity[J],Chem Pharm Bull,1996,44(11):2121
  • 9Wong S.k,Kearney P.Method for making freeze dried drug dosage form[P].US Pat.WO.95/01782,1995
  • 10Akihiko I,Masayasu.Development of oral dosage form for elderly patients:Use of agar as base of rapidly disintegrating oral tablets[J].Chem Pharm Bull,44(11):2131

共引文献58

同被引文献66

引证文献4

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部